Showing results (21-30 of 32) with videos related to
Sort By:
Pageof 4
Biomedical Chromatography : BMC|June 17, 2020
Application of tail vein serial microsampling for plasma or dried plasma spots in toxicokinetic assessment in rats using acetaminophen as the model compoundWenkui Li, Ravi Dugyala, Patrick J Devine, et al.Antimicrobial Agents and Chemotherapy|November 9, 2016
Pharmacokinetics, Distribution, Metabolism, and Excretion of Omadacycline following a Single Intravenous or Oral Dose of 14C-Omadacycline in RatsWen Lin, Jimmy Flarakos, Yancy Du, et al.Drug Metabolism Letters|April 10, 2009
Application of liquid chromatography-accelerator mass spectrometry (LC-AMS) to evaluate the metabolic profiles of a drug candidate in human urine and plasmaChandra Prakash, Christopher L Shaffer, Larry M Tremaine, et al.Analytical Chemistry|March 4, 2016
Differential Mobility Spectrometry Coupled with Multiple Ion Monitoring in Regulated LC-MS/MS Bioanalysis of a Therapeutic Cyclic Peptide in Human PlasmaYunlin Fu, Yuan-Qing Xia, Jimmy Flarakos, et al.Biomedical Chromatography : BMC|June 3, 2020
Development and validation of an LC-MS/MS method for the quantitative analysis of the adenosine A2a receptor antagonist NIR178 and its monohydroxy metabolite in human plasma: Application to clinical pharmacokineticsOlivier Heudi, Nathalie Plaud, Celine Aumonier, et al.Clinical Pharmacology in Drug Development|April 30, 2016
Bioavailability of valsartan oral dosage formsGangadhar Sunkara, Girish Bende, Anisha E Mendonza, et al.Drug Metabolism and Disposition: the Biological Fate of Chemicals|August 4, 2016
Utilization of Stable Isotope Labeling to Facilitate the Identification of Polar Metabolites of KAF156, an Antimalarial AgentSu-Er W Huskey, Ry R Forseth, Hongmei Li, et al.Clinical Pharmacokinetics|August 3, 2025
A Phase IIa, Single-Blind, Placebo-Controlled, Parallel-Group Study to Assess Safety, Tolerability, and Pharmacokinetics/Pharmacodynamics of Brensocatib in Adults with Cystic FibrosisMichael W Konstan, James J Tolle, Emily DiMango, et al.Xenobiotica; the Fate of Foreign Compounds in Biological Systems|March 3, 2016
Disposition and metabolism of [(14)C] Sacubitril/Valsartan (formerly LCZ696) an angiotensin receptor neprilysin inhibitor, in healthy subjectsJimmy Flarakos, Yancy Du, Timothy Bedman, et al.Analytical Chemistry|November 1, 2016
Compound Property Optimization in Drug Discovery Using Quantitative Surface Sampling Micro Liquid Chromatography with Tandem Mass SpectrometryXiaohui Chen, Panos Hatsis, Joyce Judge, et al.Pageof 4